# Korbato Health Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/korbato-health-co

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.korbato-health.com
- Latest round: Seed (Jun 3, 2024)
- Investors on record: 1

## About

Based in Tokyo, Japan, and founded in 2023, Korbato Health Co., Ltd., a.k.a. Korbato Health operates as a healthcare IT company that focuses on developing an electrocardiogram analysis software that uses AI to automatically analyze normal electrocardiograms to detect hidden heart diseases and uses AI to detect changes in the heart and calculate the age of the heart. In May 2024, Korbato Health raised seed funding from the Keio Innovation Initiative. As of May 2024, Ryuichiro Yagi is the CEO of the company.

The company’s flagship products include the Korbato Scan, which focuses on identifying treatable but difficult-to-detect heart conditions such as heart failure, myocardial ischemia, arrhythmias, atrial septal defects, hypertrophic cardiomyopathy, and cardiac amyloidosis. Additionally, the Korbato Heart Check utilizes AI to analyze cardiac age and predict lifestyle habits impacting heart health.

The company plans to use its proceeds from May 2024 funding to introduce the Korbato Scan product in Japan and expand into overseas markets.

## Funding rounds

- Seed, Jun 3, 2024 — Keio Innovation Initiative

## Investors

- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Seed